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Tumor suppressor function of Bruton tyrosine kinase is independent of its
catalytic activity
Sabine Middendorp, A. J. Esther Zijlstra, Rogier Kersseboom, Gemma M. Dingjan, Hassan Jumaa, and Rudolf W. Hendriks
During B-cell development in the mouse,
Bruton tyrosine kinase (Btk) and the adap-
tor protein SLP-65 (Src homology 2 [SH2]
domain–containing leukocyte protein of
65 kDa) limit the expansion and promote
the differentiation of pre-B cells. Btk is
thought to mainly function by phosphory-
lating phospholipase C2, which is
brought into close proximity of Btk by
SLP-65. However, this model was recently
challenged by the identification of a role
for Btk as a tumor suppressor in the
absence of SLP-65 and by the finding that
Btk function is partially independent of its
kinase activity. To investigate if enzy-
matic activity is critical for the tumor
suppressor function of Btk, we crossed
transgenic mice expressing the kinase-
inactive K430R-Btk mutant onto a Btk/
SLP-65 double-deficient background. We
found that K430R-Btk expression res-
cued the severe developmental arrest at
the pre–B-cell stage in Btk/SLP-65 double-
deficient mice. Moreover, K430R-Btk could
functionally replace wild-type Btk as a
tumor suppressor in SLP-65 mice: at 6
months of age, the observed pre-B-cell
lymphoma frequencies were approximately
15% for SLP-65 mice, 44% for Btk/SLP-65–
deficient mice, and 14% for K430R-Btk trans-
genic mice on the Btk/SLP-65–deficient
background. Therefore, we conclude that
Btk exerts its tumor suppressor function in
pre-B cells as an adaptor protein, indepen-
dent of its catalytic activity. (Blood. 2005;
105:259-265)
© 2005 by The American Society of Hematology
Introduction
Early in B-cell development, productive V(D)J (variable diversity
joining) recombination leads to the synthesis of immunoglobulin (Ig) 
H chain protein, which is expressed on the cell surface together with the
nonrearranging VpreB and 5 surrogate light-chain (SLC) proteins, and
forms the pre-B-cell receptor (pre-BCR; reviewed in Meffre et al1 and
Melchers et al2). It appears that the pre-BCR has a ligand-independent
signal transducing capacity, inducing phosphorylation of the Ig-/
CD79a and Ig-/CD79b signaling components and subsequently prolif-
erative expansion and differentiation into large cycling pre-B cells.3,4
Pre-BCR signaling involves the formation of a lipid raft–associated
signaling module, which is composed of the tyrosine phosphorylated
proteins Syk, the Src-family tyrosine kinase Lyn, Src homology 2 (SH2)
domain–containing leukocyte protein of 65 kDa (SLP-65; also known
as B-cell linker [BLNK] or B-cell adaptor containing SH2 domain
[BASH]), phosphoinositol 3-kinase (PI3K), Bruton tyrosine kinase
(Btk), Vav, and phospholipase C2 (PLC2).5-7 Activation of
PLC2 by Btk results in the production of the second messengers
inositol trisphosphate (IP3) and diacylglycerol (DAG), which
activate calcium signaling and protein kinase C (PKC), respec-
tively.8,9 The pre-BCR is transiently expressed on the cell surface,
whereby the signaling molecules SLP-65 and Btk are important for
the developmental progression of large cycling into small resting
pre-B cells in which Ig L chain rearrangement occurs (reviewed in
Hendriks and Middendorp10).
By analogy with the BCR in mature B cells, Btk is thought to be
phosphorylated by Syk or Lyn upon recruitment to the pre-B-cell
membrane through binding of its pleckstrin homology (PH)
domain to the PI3K product phosphatidyl-inositol trisphosphate
(PIP3).11,12 In this signaling pathway, phosphorylated SLP-65 plays
an essential role as it provides docking sites for phosphorylated Btk
as well as PLC2 and thus brings Btk in close proximity with
PLC2.13,14 However, this model is challenged by several indepen-
dent observations.
Firstly, Btk can also act as adaptor molecule, independent of its
catalytic activity. Expression of kinase-inactive Btk mutants have
been shown to partially or fully reconstitute BCR-induced calcium
mobilization in Btk-deficient chicken DT40 and human A20
mature B-cell lines.8,15,16 In addition, phosphorylation of PLC2
upon BCR stimulation is apparently unaffected in human Btk-
deficient B-cell lines.17 We have recently shown that during in vivo
B-cell development, Btk function is in part independent of its
catalytic activity, as transgenic expression of the kinase-inactive
K430R-Btk mutant partially restored pre-B cell and B-cell defects
in Btk-deficient mice.18
Secondly, in mature A20 B cells, Btk is essential for the
recruitment of phosphatidylinositol phosphate 5-kinase (PIP5K) to
the membrane, whereby enzymatic activity of Btk is not required
for its association with PIP5K.15 Activation of PIP5K leads to local
synthesis of PIP2, which is a common substrate shared by both
PI3K and PLC2. As a result, a positive feedback loop is initiated
that allows Btk to stimulate the production (by PI3K) of PIP3,
which is required for sustained Btk localization to the plasma
membrane. At the same time, the shuttling function of Btk also
provides substrate for sustained PLC2 activity.12,15
Thirdly, Btk/SLP-65 double-deficient mice show an almost
complete block in B-cell development at the pre-B-cell stage when
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compared with the partial block at this stage in SLP-65 or Btk
single-mutant mice,19-21 indicating that Btk and SLP-65 partially
function in parallel pathways. Both Btk and SLP-65 are essential
for the regulation of pre-B-cell development, in particular by
limiting pre-B-cell expansion at the transition of large cycling into
small pre-B cells.22-26 SLP-65 mice spontaneously develop pre-B-
cell lymphomas expressing high levels of the pre-BCR on the cell
surface.20,27 Although Btk-deficient mice do not develop pre-B-cell
tumors, we recently found that Btk cooperates with SLP-65 as a
tumor suppressor because the incidence of pre-B-cell lymphomas
was significantly higher in Btk/SLP-65 double-mutant mice when
compared with SLP-65 single-deficient mice. Moreover, transgenic
expression of the constitutive active E41K-Y223F Btk mutant,
which shows enhanced membrane localization,28,29 prevented tu-
mor formation in Btk/SLP-65 double-deficient mice.21
Importantly, the finding of defective SLP-65 expression in
approximately 50% of childhood pre-B acute lymphoblastic leuke-
mias (ALLs) indicated that SLP-65 also acts as a tumor suppressor
in pre-B cells in humans.30 The loss of SLP-65 protein was
apparently due to the incorporation of alternative exons into
SLP-65 transcripts, leading to premature stop codons.30 Moreover,
in human Bcr-Abl pre-B ALL, the activity of the Bcr-Abl1 kinase
was found to be linked to defective pre-B signaling and the
expression of the same aberrant SLP-65 transcripts.31 It was also
observed that a large fraction of childhood pre-B ALL cases
manifested aberrant Btk transcripts predicted to encode Btk
proteins with a substantial kinase domain deletion.32
The mechanism by which Btk exerts its tumor suppressor
function in pre-B cells independent of SLP-65 is currently un-
known. By analogy with the findings in mature A20 B cells, Btk
may function in pre-B cells as an adaptor molecule to localize
PIP5K to the plasma membrane. However, it remains possible that
this PIP5K shuttling mechanism that allows Btk to stimulate
PLC2 is dependent on the presence of SLP-65 (eg, as a scaffold
molecule to bring Btk or other tyrosine kinase proteins, such as Syk
or Src-family kinases, in close proximity with PLC2).
In this study, we investigated whether Btk tumor suppressor
function is independent of its kinase activity and at the same time
whether SLP-65 is required for adaptor function of Btk. To this end,
we crossed transgenic mice expressing the kinase-inactive Btk
mutant K430R onto a Btk/SLP-65 double-deficient background
and found that kinase-inactive Btk was able to functionally replace
wild-type Btk as a tumor suppressor in the absence of SLP-65.
Materials and methods
Mice and genotyping
Btk-deficient mice33 and SLP-65–deficient mice22 were on the C57BL/6
and Balb/c background, respectively. Wild-type and targeted alleles were
identified as described previously.21,26 Btk-K430R transgenic mice, in
which B-cell–specific expression of human Btk is under the control of the
CD19 promoter region, were on a mixed C57Bl/6  FvB background. The
presence of the Btk-K430R transgene was evaluated by polymerase chain
reaction (PCR).18
Flow cytometry and Ig ELISA
Standard and intracellular flow cytometry and conjugated monoclonal
antibodies (BD Biosciences, Mountain View, CA) have been described
previously.26,33 The anti-SLC hybridoma LM3434 was kindly provided
by A. Rolink (University of Basel, Basel, Switzerland). Levels of Ig
subclasses in serum were measured by sandwich enzyme-linked immu-
nosorbent assay (ELISA).35
Cell culture and Western blotting
Total bone marrow (BM) cells or pre–B-lymphoma cells were cultured in
the presence of 100 U/mL interleukin 7 (IL-7; Sigma-Aldrich, St Louis,
MO) as described.26 For analysis of Btk phosphorylation, cells were
stimulated with 10 g/mL F(ab	)2 fragment of polyclonal goat antimouse
IgM (Jackson Immuno Research, Westgrove, PA) in RPMI1640 at 37°C.
Total cell lysates of unstimulated and stimulated cells were immunoprecipi-
tated overnight at 4°C with antiphosphotyrosine (pTyr-100; Cell Signaling
Technology, Beverly, MA) and samples were blotted using standard sodium
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) proce-
dures.36 Western blots were stained with anti-Btk C-20 (SantaCruz Biotech-
nology, Santa Cruz, CA) to detect Btk protein. Routinely, a small fraction of
the total cell lysates were blotted with pTyr-100 to verify pre-BCR
stimulation.21
Ca2 mobilization assay
Cells were loaded with 6 g/mL indo-1 acetoxymethylester (indo-1 AM;
Molecular Probes Europe, Leiden, The Netherlands) at 37°C for 45 minutes
and subsequently stained with phycoerythrin (PE)–labeled anti-CD4,
anti-NK1.1, anti-Ter119, anti-CD11b, and fluorescein isothiocyanate (FITC)–
labeled anti-CD8 monoclonal antibodies (BD Biosciences). Cells were
stimulated by 20 g/mL F(ab	)2 fragment of polyclonal goat antimouse
IgM (Jackson Immuno Research) and subsequently by 2 g/mL ionomycin
as a positive control. Fluorescence ratios (FL-5/FL-4) were measured on a
FACS-VantageSE/DiVa (BD Biosciences) and data for B cells
(CD4CD8NK1.1Ter119CD11b) were analyzed by FlowJo (Tree Star,
Ashland, OR) multiparameter flow application.
Results
Kinase-inactive Btk stimulates calcium mobilization in
mature B cells
We previously showed that transgenic expression of the kinase-
dead Btk mutant K430R partially rescued Btk function in vivo,
including the induction of nuclear factor 
B (NF-
B) and the
expression of Bcl-xL and cyclin D2 in splenic B cells upon BCR
stimulation.18 To investigate whether these effects are mediated by
the ability of K430R-Btk to potentiate calcium flux, we evaluated
calcium mobilization in splenic B cells in response to BCR
engagement in K430R-Btk transgenic mice on a Btk-deficient
background, in comparison with wild-type and Btk-deficient mice
(Figure 1A). Btk-deficient B cells showed a significantly reduced
BCR-mediated Ca2 signal when compared with wild-type B cells.
Transgenic K430R-Btk provided complete correction of the Ca2
response in Btk-deficient B cells, indicating that Btk stimulates
calcium flux independent of its catalytic activity.
SLP-65 is not required for pre-BCR–induced tyrosine
phosphorylation
If Btk and SLP-65 can function independently in parallel pathways
in pre-B cells, this implies that Btk can be activated in the absence
of SLP-65. It was previously shown that in SLP-65 pre-B-cell
lines, established by long-term IL-7–dependent bone marrow
culture, the pre-BCR is signaling competent, whereby pre-BCR
stimulation led to phosphorylation of Ig-, Syk, Lyn, PI3K, and
PLC2.20 We evaluated phosphorylation of Btk in stable SLP-65–
deficient pre-B-cell lines expressing high levels of pre-BCR on the
cell surface, which we established from SLP-65 pre-B-lymphoma
cells.21 Pre-B cells were stimulated with antibodies specific for Ig 
H chain, tyrosine-phosphorylated proteins were immunoprecipi-
tated from total cellular lysates using pTyr-specific monoclonal
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antibodies, and Btk protein was identified by blotting with a
Btk-specific antibody. As shown in Figure 1B, pre-BCR stimula-
tion in SLP-65–deficient pre-B cells resulted in Btk phosphoryla-
tion. Similar results were obtained in pre-BCR stimulation of
short-term IL-7–dependent bone marrow–derived cultured pre-B
cells from tumor-free SLP-65 mice (data not shown). These
findings show that in murine pre-B cells, Btk can be phosphory-
lated upon pre-BCR stimulation in the absence of SLP-65.
Transgenic K430R-Btk expression partially corrects the defects
in B-cell development in Btk/SLP-65 double-mutant mice
Mice deficient for either Btk or SLP-65 have a partial block in
B-cell development at the pre-B-cell stage in the BM, whereas
Btk/SLP-65 double-deficient mice have an almost complete block
at this stage.19,22-26 We have previously shown that expression of
transgenic kinase-inactive K430R-Btk is able to partially rescue the
mild differentiation defects at the pre-B-cell stage and the more
severe block in peripheral B-cell maturation in Btk-deficient
mice.18 To investigate to what extent the K430R-Btk transgene can
reconstitute the almost complete pre-B-cell differentiation block in
Btk/SLP-65 double-deficient mice, we compared the size of the
B-cell subpopulations in spleen and BM by flow cytometry in 6
different mouse groups: Btk, Btk, or K430R-Btk transgenic on a
Btk background, each of which were either SLP-65 or SLP-65.
In agreement with our reported findings,18 reconstitution with
K430R-Btk partially overcame the block in peripheral B-cell
maturation present in Btk-deficient mice (Table 1; Figure 2A).
Also, consistent with previous findings,19,21 the size of the total
splenic B-cell population in Btk/SLP-65 double-deficient mice was
severely reduced (1.7  106 cells) when compared with wild-
type or each of the single-deficient mice (Table 1). Expression of
K430R-Btk in Btk/SLP-65 double-deficient mice increased the size
of the total B-cell population in the spleen with a factor of
approximately 4 (to 7.1  106 cells). This reconstitution was only
partial, since the total numbers of splenic B cells in SLP-65 mice
were significantly higher (22  106 cells; Table 1). Nevertheless,
Figure 1. Kinase domain–independent and SLP-65–independent function of
Btk. (A) K430R-Btk stimulates calcium flux in response to BCR activation. Indo-1
AM–loaded splenic B cells of the indicated mice were stimulated with anti-IgM F(ab	)2
fragments and calcium flux was monitored. The plots are representative for 2 to 4
mice of each genotype. (B) Btk phosphorylation in the absence of SLP-65. Cultured
cells from 2 different SLP-65 pre-B-cell lymphomas (BL no. 1 and BL no. 2) were
either not stimulated or stimulated for 1 or 5 minutes with polyclonal anti-IgM F(ab	)2
fragments. The presence of Btk in antiphosphotyrosine immunoprecipitates from total
cellular lysates was analyzed by Western blotting using Btk-specific antibodies.
Table 1. Absolute numbers of B-cell subpopulations in spleen and bone marrow
n* Spleen†
Bone marrow
Pro-B cells† Pre-B cells† Immature B cells† Mature B cells†
Mouse strain NA B220 B220c B220cIgM IgMIgD IgMIgD
Btk 14 (5) 61.0  9.3 2.6  0.3 13.8  1.1 3.9  1.3 3.7  0.7
Btk 13 (5) 11.9  1.3 3.0  0.3 11.9  1.0 3.9  0.3 2.0  0.2
K430R-Btk 5 23.1  4.5 2.8  0.4 12.8  2.0 3.8  0.8 2.0  0.7
SLP-65 5 21.7  5.0 3.0  0.5 12.8  2.3 3.1  0.6 1.5  0.4
BtkSLP-65 5 1.7  0.3 3.7  0.3 8.2  1.6 1.1  0.3 0.1  0.0
K430R-Btk/SLP-65 7 7.1  1.6‡ 2.8  0.3 10.4  1.6 2.6  0.4 0.7  0.2
NA indicates not applicable.
*Number of mice analyzed; the numbers in parentheses indicate that the B-cell population in spleen was analyzed in 5 mice per group.
†Absolute number as average SEM (106).
‡The absolute numbers of splenic B220 cells in K430R-Btk/SLP-65 mice were significantly different from the values in SLP-65 mice (P  .008) and in Btk/SLP-65
double-deficient mice (P  .025).
Figure 2. K430R-Btk partially corrects the defects in B-cell development in
Btk/SLP-65 double-mutant mice. Flow cytometric analysis of (A) spleen and (B) bone
marrow of Btk, Btk, and K430R-Btk mice on either the SLP-65 or the SLP-65
background. (A) IgM/IgD profiles of total splenic lymphoid cells, (B) IgM/B220, and (C)
IgM/IgD profiles of total bone marrow lymphoid cells. Lymphoid cells were electronically
gated on the basis of forward and side scatter characteristics. Data are presented as dot
plots and the percentages within the indicated quadrants or gates are given. The plots are
representative for 5 to 14 mice of each genotype.
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the residual B cells present, which failed to differentiate into
IgMlowIgDhigh B cells in Btk/SLP-65 double-deficient mice, in part
differentiated to IgMlowIgDhigh mature B cells when the K430R-Btk
transgene was present (Figure 2A).
In the bone marrow, the Btk, K430R-Btk, and SLP-65 mice
differed from wild-type mice by an approximately 50% reduction
in the size of the mature IgMIgD population of recirculating B
cells (Table 1). By contrast, the Btk/SLP-65 double-deficient mice
manifested a dramatic reduction in the total numbers of both
immature IgMIgD and mature IgMIgD B cells. Importantly,
the size of the immature B-cell population was similar in K430R-
Btk/SLP-65 mice (2.6  106) and SLP-65 mice (3.1  106).
Thus, in the absence of SLP-65, kinase-inactive K430R-Btk could
functionally replace Btk at the developmental progression from
pre-B cells into immature B cells. From the analysis of IgM/IgD
profiles of the B220 population (Figure 2C), it is clear that
SLP-65 and K430R-Btk/SLP-65 mice contained similar frac-
tions of IgMIgD immature B cells (12%). Expression of the
K430R-Btk transgene only partly restored the reduction of the size
of the mature IgMIgD B-cell population observed in Btk/SLP-
65 mice (Figure 2B-C; Table 1).
In summary, these flow cytometric analyses show that expres-
sion of kinase-inactive Btk can partially correct the severe B-cell
differentiation defect in Btk/SLP-65 double-deficient mice, whereby
the level of reconstitution is more complete in immature B cells
than in mature B cells. Therefore, these results indicate that in
SLP-65–independent signaling pathways, Btk kinase activity is not
critical for the transition of pre-B cells into immature B cells and is
apparently more important for the maturation of peripheral B cells.
Btk kinase activity is specifically required for IgG3 production
To further investigate if the Btk kinase domain is essential for the
synergistic role of Btk and SLP-65 in mature B cells, we
investigated the serum Ig levels in the 6 mouse groups. When
compared with wild-type mice, Btk and SLP-65 mice have
severely decreased levels of IgM and IgG3, whereas other
isotypes are generally not affected.22-25,37 We have previously
found that kinase-inactive Btk could significantly restore the
decreased levels of IgM in serum of Btk-deficient mice, but only
a limited correction of serum IgG3 was observed.18 As shown in
Figure 3, Btk/SLP-65 double-deficient mice have reduced serum
levels of all isotypes when compared with each of the single-
mutant littermates. Serum Ig levels in K430R transgenic Btk/
SLP-65 double-deficient mice were restored to levels similar to
those found in SLP-65 single-deficient mice (Figure 3), except
for IgG3. In fact, serum IgG3 levels in Btk/SLP-65 double-
deficient and K430R-Btk/SLP-65 mice were very low, close to
the lower detection limit of the ELISA.
Taken together, these results indicate that, with respect to late
B-cell and plasma cell differentiation, in the absence of SLP-65,
Btk mainly acts as a scaffolding protein. Only for the differentia-
tion of B cells into IgG3-producing plasma cells is Btk kinase
activity essential.
K430R-Btk can functionally replace wild-type Btk in cellular
maturation of SLP-65–deficient pre-B cells
We have previously shown that Btk and SLP-65 are required for
efficient transition of large cycling into small resting cytoplas-
mic  pre-B cells.21,26 In Btk or SLP-65 mutant mice, the
down-regulation of the pro-B/large pre-B-cell–specific expres-
sion of SLC, CD43, and BP-1/6C3 aminopeptidase A and the
up-regulation of CD2, CD25, and major histocompatibility
complex (MHC) class II on small pre-B cells are impaired. A
synergistic role for Btk and SLP-65 in this context is clear from
the more pronounced defects in the modulation of these markers
in Btk/SLP-65 double-deficient mice.21,26 We also reported that
kinase-inactive Btk is able to partially restore the defects at the
pre-B-cell stage in Btk-deficient mice.18
To investigate the effects of K430R-Btk on pre-B-cell matura-
tion in the absence of SLP-65, we compared the surface IgM
pro-B/pre-B-cell fraction of Btk, Btk, and K430R-Btk trans-
genic mice, either on an SLP-65 or an SLP-65 background. We
analyzed the expression of various developmentally regulated
markers, including SLC, CD25, and MHC class II by flow
cytometric analysis. In wild-type cells, only a small proportion of
 pre-B cells expressed SLC (7%; Figure 4A). As previously
reported,18,21 transgenic K430R-Btk was able to restore the im-
paired down-regulation of SLC expression in Btk-deficient mice,
whereas Btk/SLP-65 double-mutant mice manifested a much more
severe defect in SLC down-regulation (71% SLC pre-B cells).
Interestingly, the levels of SLC expression in K430R-Btk/SLP-65
and SLP-65 single-deficient pre-B cells were similar (43%
SLC pre-B cells; Figure 4A), indicating that K430R-Btk could
completely replace wild-type Btk function with respect to SLC
down-regulation. Likewise, the levels of CD25 and MHC class II
induction in K430R-Btk/SLP-65 pre-B cells (38% and 32%,
respectively) were comparable to those in SLP-65 pre-B cells
(56% and 21%) and significantly higher than those in Btk/
SLP-65 double-mutant mice (18% and6%).
In summary, these analyses show that transgenic expression of
kinase-inactive Btk is able to reduce the severe pre-B-cell matura-
tion defects in Btk/SLP-65 double-deficient mice to a level that is
comparable with SLP-65 single-deficient pre-B cells. Therefore,
we conclude that in the absence of SLP-65, Btk signaling
contributes to cellular maturation of pre-B cells, independent of its
kinase activity.
K430R-Btk can functionally replace wild-type Btk as a tumor
suppressor in SLP-65 mice
Concomitant deficiency of Btk strongly increases the frequency of
pre-B-cell lymphoma formation in SLP-65 mice, demonstrating
that Btk cooperates with SLP-65 as a tumor suppressor in pre-B
cells.21 To investigate whether the tumor suppressor function of Btk
is dependent on its kinase activity, we examined the capacity of
Figure 3. K430R-Btk restores serum Ig levels in Btk/SLP-65 double-mutant
mice. Serum concentrations of IgM, IgG1, IgG2a, IgG2b, IgG3, and IgA, as
determined by ELISA, are shown for the indicated mouse strains. Mice were 2
months of age and each symbol represents an individual animal.  indicates Btk; ‚,
Btk; E, K430R-Btk; f, Btk SLP-65; Œ, Btk SLP-65; and F, K430R-Btk
SLP-65.
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K430R-Btk to substitute for Btk by following a panel of K430R-
Btk transgenic mice for 180 days. At this age, 18 (15%) of 123
SLP-65 single-deficient mice developed a pre-B-cell lymphoma,
whereas the Btk/SLP-65 double-deficient mice showed a frequency
of approximately 44% (47 of 107). In contrast, only 7 (14%) of
51 K430R-Btk/SLP-65–deficient mice developed a pre-B-cell
lymphoma (Figure 5). From these results we conclude that
transgenic kinase-inactive Btk can substitute for the endogenous
wild-type Btk as a tumor suppressor in SLP-65–deficient mice, and
therefore that the tumor suppressor function of Btk in pre-B cells is
independent of its kinase activity.
Discussion
The finding that the block in B-cell differentiation and the
associated pre-B-cell lymphoma formation in SLP-65 mice is
much more severe when Btk is concomitantly mutated suggested
that the 2 proteins do not function only in a common signal
transduction pathway. In this study, we demonstrate that during
pre-B-cell development in the mouse, Btk functions as an adaptor
molecule in an SLP-65–independent pathway.
We found that transgenic expression of the kinase-inactive
K430R-Btk mutant was able to rescue the severe defects present in
Btk/SLP-65 double-deficient pre-B cells to such an extent that the
resulting phenotype was similar to that of SLP-65 single-deficient
mice. In particular, we found that in the absence of SLP-65, Btk can
act as an adaptor molecule that signals the modulation of SLC,
CD25, and MHC class II expression in pre-B cells. Importantly, the
Btk kinase activity is also not required for its function as a tumor
suppressor in SLP-65–deficient pre-B cells. Expression of the
K430R-Btk transgene also restored the severe defects in mature B
cells, although total B-cell numbers in the spleen and serum IgG3
levels were still reduced in K430R-Btk transgenic mice on the
Btk/SLP-65 double-deficient background compared with SLP-65
single-deficient mice. This partial inability of K430R-Btk to
substitute for Btk in mature B cells could reflect their absolute
dependence on Btk kinase activity. Alternatively, this might be
related to the expression pattern of the K430R-Btk transgene,
which is under the control of the CD19 promoter region. While the
expression level is in the physiologic range in the bone marrow
(1-2  endogenous levels), this increases significantly as immature
B cells differentiate to mature peripheral B cells (15  overex-
pression). Therefore, it is possible that transgenic K430R-Btk
expression partly has dominant-negative effects in vivo, which
would be supported by our previous finding of reduced serum IgG3
levels and T-cell–independent IgM responses in K430R-Btk trans-
genic mice on a Btk wild-type background.18
The mechanism by which Btk functions as an adaptor molecule
in pre-B cells is not known, but it is attractive to hypothesize that
equivalent to the findings in mature A20 B cells, Btk may associate
with PIP5K and recruit this enzyme to the plasma membrane.15 As
overexpression of PIP5K was reported to lead to an increase in the
sustained calcium response upon BCR activation,12 it is assumed
that by providing the substrate PIP2 for PLC2, PIP5K recruitment
by Btk is sufficient to induce production of IP3 and DAG by
PLC2. This mechanism would then explain the ability of kinase-
inactive Btk to induce calcium mobilization in B cells upon BCR
stimulation (Figure 1A). In this model, Btk should be recruited to
the membrane and activated in an SLP-65–independent fashion.
Although it has been proposed that Btk phosphorylation would be
SLP-65 dependent,13 other data including ours favor a model in
which Btk activation is SLP-65 independent (Fu et al38 and Chiu et
al39; Figure 1B).
Taken together, our findings provide the biochemical basis for a
parallel SLP-65–independent escape route when Btk is not able to
phosphorylate PLC2 directly: upon pre-BCR expression, Lyn,
Syk, and PI3K are activated, resulting in phosphorylation and
membrane translocation of Btk. Activated Btk is able to recruit
PIP5K, which provides substrate for both PLC2 and PI3K. This
mechanism may also explain the phenotype of CD19/SLP-65
double-deficient mice, in which pre-B-cell differentiation was also
almost completely blocked,27 quite similar to the phenotype of
Figure 4. K430R-Btk corrects pre-B-cell maturation in Btk/SLP-65 double-
mutant mice. Flow cytometric analysis of gated surface IgM-negative B220
pro-/pre-B cells of Btk, Btk, and K430R-Btk mice on either an SLP-65 or the
SLP-65 background. B220IgM cells were gated and analyzed for the expression
of (A) cytoplasmic Ig H chain (c)/SLC, (B) c/MHC, class II, and (C) forward
scatter (FSC)/CD25. Data are displayed as dot plots and the percentage of cells
within the indicated gates are given. Data shown are representative of 5 to 14 mice
analyzed within each group.
Figure 5. Tumor suppressor function of Btk is not dependent on its kinase
activity. Kaplan-Meier tumor-free survival estimates for SLP-65 (n  123), BtkSLP-
65 (n  107), and K430R-Btk mice on the BtkSLP-65 background (n  51).
Tumor-free survival in Btk/SLP-65 double-deficient mice was significantly reduced
compared with SLP-65 mice (P  .00001, by log-rank) and to K430R-Btk/SLP-65
mice (P  .0008). Tumor-free survival in the SLP-65 and K430R-Btk/SLP-65
groups of mice was not significantly different.
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Btk/SLP-65 double-deficient mice.19,21 From the findings in CD19/
SLP-65 double-deficient mice, it was concluded that the pre-B-cell
transition, including cell cycle progression, down-regulation of
recombination-activating gene 2 (RAG-2) protein, and SLC expres-
sion, as well as transcriptional activation of the Ig 
 locus, which is
principally mediated by SLP-65, can also be (inefficiently) ex-
ecuted by CD19.27 In addition, in reconstituted myeloma cells,
CD19 has been shown to be necessary for efficient BCR-mediated
activation of Btk,40 most likely through the PI3K pathway and the
production of PIP3 in concert with Lyn- or Syk-mediated phosphor-
ylation of Btk.41,42 Therefore, we propose that the SLP-65–
independent parallel PLC2 activation pathway in pre-B cells
requires both Btk (as an adaptor protein) and CD19-dependent
PIP3 synthesis by PI3K. In this model, a direct interaction between
Btk and PLC2 is not required and Btk and PIP5K would interact
in the absence of SLP-65.
A possibility remains that SLP-65 deficiency can be compen-
sated by the presence of redundant proteins because the concomi-
tant absence of linker of activated T cells (LAT) in SLP-65 mice
resulted in an almost complete block at the large pre-B-cell stage.43
Furthermore, it was shown that upon pre-BCR engagement, LAT
recruits PLC2 to the pre-BCR by association with Ig- and the
SLP-65 homologue SLP-76. These results indicate that LAT/
SLP-76 can rescue PLC2 activation in the absence of SLP-65.43
However, in this model the capacity of LAT/SLP-76 to replace
SLP-65 function would be dependent on the presence of Btk as an
adaptor molecule. Although SLP-65 or LAT/SLP-76, together with
Btk, may serve as a scaffold to bring other kinase proteins in close
proximity to PLC2, phosphorylation of 2 of 4 regulatory tyrosines
in PLC2 appears to be entirely dependent upon Btk/Tec-family
kinases, whereas Syk/zeta-associated protein 70 (ZAP-70) fails to
modify these sites.44 Further experiments are required to investi-
gate if Btk can interact with LAT or SLP-76.
In summary, our results show that Btk not only activates PLC2
by phosphorylation in a complex with SLP-65 but also has a
scaffolding function in an SLP-65–independent pathway in pre-B
cells. This kinase-independent Btk function provides the molecular
basis of the observed cooperation of Btk with SLP-65 as a tumor
suppressor in pre-B cells. Based on recent findings in mature B
cells,15 we hypothesize that Btk tumor suppressor function involves
its capacity to recruit PIP5K to the membrane, which allows Btk to
provide substrate for PLC2.
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